About us
Pipeline
Target Markets
Our Technologies
Partnering
News, Media & Events
Investors
Careers
Contact
Home
News, Media & Events
Media Coverage
Neil Clark & Shaun Claydon of Destiny Pharma: Significant progress in H1 will continue in 2022 & beyond – Vox Markets
Neil Clark & Shaun Claydon of Destiny Pharma: Significant progress in H1 will continue in 2022 & beyond – Vox Markets